| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |